Daewon Pharmaceutical Co., Ltd. (KRX:003220)
South Korea · Delayed Price · Currency is KRW 7,850.00
-10.00 (-0.13%)
Sep 18, 2026, 3:30 PM KST
Daewon Pharmaceutical Market Cap
Daewon Pharmaceutical has a market cap or net worth of 168.25 billion as of September 18, 2026. Its market cap has decreased by -40.71% in one year.
Market Cap
168.25B
Enterprise Value
299.27B
Revenue
614.64B
Ranking
n/a
PE Ratio
39.01
Stock Price
7,850.00
ChartMarket Cap Chart
Since March 1, 2001, Daewon Pharmaceutical's market cap has increased from 18.06B to 168.25B, an increase of 831.63%. That is a compound annual growth rate of 9.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 168.25B | -34.31% |
| Dec 30, 2025 | 256.13B | -16.14% |
| Dec 30, 2024 | 305.43B | -7.98% |
| Dec 28, 2023 | 331.93B | -15.58% |
| Dec 29, 2022 | 393.20B | 14.64% |
| Dec 30, 2021 | 343.00B | -9.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Yungjin Pharm. | 190.39B |
| BNC KOREA | 190.14B |
| Whan In Pharm | 186.50B |
| REYON Pharmaceutical | 185.98B |
| Chong Kun Dang Holdings | 180.19B |
| AptaBio Therapeutics | 174.18B |
| JW Lifescience | 169.56B |
| Samil Pharmaceutical Co.,Ltd | 165.84B |